Esperion Theraptc (NQ: ESPR )
2.500
-0.010
(-0.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 15, 2024
Add to My Watchlist
All News about Esperion Theraptc
![](https://images.pexels.com/photos/4033021/pexels-photo-4033021.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://ml.globenewswire.com/media/6af55bc4-856a-4007-b242-baeb422ba7e7/small/esperion-logo-primary-png.png)
![](https://ml.globenewswire.com/media/6af55bc4-856a-4007-b242-baeb422ba7e7/small/esperion-logo-primary-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6af55bc4-856a-4007-b242-baeb422ba7e7/small/esperion-logo-primary-png.png)
Esperion to Participate in January Investor Meetings
December 13, 2022
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_1757.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7545.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_4914.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/07/espr_logo_light__938641258c23cd69901234f21d67187f.png?width=1200&height=800&fit=crop)
Esperion Therapeutics Reports Sooner Than Expected Positive Data From Nexletol Trial
December 07, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/6af55bc4-856a-4007-b242-baeb422ba7e7/small/esperion-logo-primary-png.png)
![](https://ml.globenewswire.com/media/6af55bc4-856a-4007-b242-baeb422ba7e7/small/esperion-logo-primary-png.png)
Esperion Appoints Ben Halladay Chief Financial Officer
November 16, 2022
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3477.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/6af55bc4-856a-4007-b242-baeb422ba7e7/small/esperion-logo-primary-png.png)
![](https://ml.globenewswire.com/media/6af55bc4-856a-4007-b242-baeb422ba7e7/small/esperion-logo-primary-png.png)
Esperion to Participate in Jefferies London Healthcare Conference
November 02, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6af55bc4-856a-4007-b242-baeb422ba7e7/small/esperion-logo-primary-png.png)
![](https://ml.globenewswire.com/media/6af55bc4-856a-4007-b242-baeb422ba7e7/small/esperion-logo-primary-png.png)
Esperion Hosting Virtual Research & Development Day
October 27, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6af55bc4-856a-4007-b242-baeb422ba7e7/small/esperion-logo-primary-png.png)
![](https://ml.globenewswire.com/media/6af55bc4-856a-4007-b242-baeb422ba7e7/small/esperion-logo-primary-png.png)
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_24059.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/03/image27.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/02/biotech4.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_8196.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_10309.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/05/peek_into_the_marketnew.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/03/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_3674.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_4298.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_4484.jpeg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.